GSK Malaria Vaccine (candidate 257049)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK Malaria Vaccine (candidate 257049), covering 2014-02-10 to 2014-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) [Phase 3]